Vanguard Group Inc Eton Pharmaceuticals, Inc. Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Eton Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,027,688 shares of ETON stock, worth $13.4 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,027,688
Previous 1,027,688
-0.0%
Holding current value
$13.4 Million
Previous $3.38 Million
82.37%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding ETON
# of Institutions
51Shares Held
9.44MCall Options Held
261KPut Options Held
500-
Opaleye Management Inc. Boston, MA2.78MShares$36.3 Million3.05% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT999KShares$13 Million0.36% of portfolio
-
Westside Investment Management, Inc.619KShares$8.07 Million0.79% of portfolio
-
Acuitas Investments, LLC580KShares$7.57 Million1.66% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA566KShares$7.39 Million0.15% of portfolio
About Eton Pharmaceuticals, Inc.
- Ticker ETON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,297,000
- Market Cap $330M
- Description
- Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...